BioSpace News Archive

Business

Activist Investor Takes $1B Stake in BioMarin Amid CEO Change, Disappointing Sales

Activist hedge fund investor Elliott Investment Management has bought over a $1 billion stake in BioMarin as the biotech grapples with a leadership change and disappointing sales of its hemophilia A gene therapy.

November 8, 2023
·
2 min read
·
Tristan Manalac
Business

Q3 earnings recap: Winners, losers & surprises

This week, in (our inaugural episode!) BioSpace’s Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma’s reported Q3 earnings. They also tackle what’s going on at Pfizer, ADCs, deals and more.

November 8, 2023
·
1 min read
Business

Eisai Sees ‘Dramatic’ Increase in Leqembi Uptake Following Full FDA Approval

After winning traditional approval from the U.S. regulator, Eisai’s Alzheimer’s disease therapy Leqembi has seen a sharp increase in patient uptake, with a target of 10,000 patients by March 2024.

November 8, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Harnessing Social Media for Clinical Trial Recruitment

A failed rare disease clinical trial brings social media expertise to the pharma industry and patient recruitment: A discussion with Bryan Manning, founder of Clinical Enrollment and Two Blind Brothers

November 8, 2023
·
6 min read
·
BioSpace Insights
Business

Gilead Q3 Revenue Stagnates, Drops Late-Stage COVID-19 and AML Trials

The third-quarter growth of Gilead’s HIV, oncology and cell therapy businesses was completely offset by declining COVID-19 and liver disease sales, with revenue flat compared to the same period last year.

November 8, 2023
·
2 min read
·
Tristan Manalac
Business

Bayer Eyes Break-Up, Management Cuts on Disappointing Q3 Results

The company on Wednesday reported nearly 50 billion euros, or $53.3 billion, in revenue with zero cash flow. Several layers of management will be eliminated as structural split-off strategies are considered.

November 8, 2023
·
2 min read
·
Kate Goodwin
Career Advice

Top Companies Hiring Research Associates Right Now

Research associates are always in demand. Check out these top companies currently hiring RAs.

November 8, 2023
·
1 min read
·
Editorial Staff
Business

Biopharma’s Q3 Earnings Season Sees Mixed Results as Challenges Remain

With headwinds in the wider biotech sphere, the third quarter showed continuing vulnerabilities in the COVID space while the weight-loss drugs drove blockbuster sales.

November 8, 2023
·
5 min read
·
Tyler Patchen
FDA

FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management

Lilly’s Zepbound (tirzepatide) injection is the first and only approved treatment that activates two incretin hormone receptors, GIP and GLP-1, to treat obesity and excess weight.

November 8, 2023
·
2 min read
·
Tyler Patchen
Policy

Addex Regains Nasdaq Listing Compliance

Addex Therapeutics announced it had received written notification from The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement of $1.00 per ADS under Nasdaq Listing Rule 5550 and currently meets all other applicable criteria for continued listing.

November 8, 2023
·
3 min read